CGD Policy Blogs

Initiative

Expert

 

An R&D Treaty and Medical Innovation Prize Fund

The Consumer Project on Technology (www.cptech.org) has proposed a Medical R&D Treaty. The aim is to replace trade agreements that focus on patents or drug prices with minimum national obligations for supporting medical R&D. There would be freedom for countries to decide for themselves how to fulfil their commitment to support R&D, using their chosen combination of intellectual property rules and patents, public funding, advance commitments, or open source collaborations.

An R&D Treaty and Medical Innovation Prize Fund

The Consumer Project on Technology (www.cptech.org) has proposed a Medical R&D Treaty. The aim is to replace trade agreements that focus on patents or drug prices with minimum national obligations for supporting medical R&D. There would be freedom for countries to decide for themselves how to fulfil their commitment to support R&D, using their chosen combination of intellectual property rules and patents, public funding, advance commitments, or open source collaborations.

More Detail from Gordon Brown

In today's Observer (the Sunday sister newspaper of the Guardian), Gordon Brown sets out his plan to fight disease.

Our focus will be a plan to support a new international platform for research into vaccines and cures, public-private partnerships and advance purchase schemes for their development and, finance, to build the capacity of health-care systems.

On advance purchase agreements, he says:

Brown Commitment on Vaccines

Gordon Brown announcing his plansGordon Brown made an important speech today setting out the UK's development agenda for the G8 meeting at Gleneagles.

It is an extraordinary fact that a finance facility for immunisation, raising an extra $4 billion ahead of 2015 for vaccinations, could save an extra 5 million lives over the next 10 years. In the years after 2015 another 5 million more lives could be saved.

Honduras Closer to MCA Vision

MCA watchers have been concerned about a seeming lack of civil society participation in proposal design in MCA-eligible countries. That participation is one of MCA's main objectives. Some observers claim that in some countries civil society contributes only at the periphery of the debate while the business community leads the process. Honduras may be different.

BioMedical Industry Advisory Group Submission to CIPIH

The Biomedical Industry Advisory Group has provided a substantial submission to the Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH).

The submission calls upon political leaders to improve the R&D environment for neglected diseases.

As a crucial first step, political leaders must set a public health agenda to establish targeted policies. With these in place, biomedical companies R&D can help address the need for improved therapies through a series of initiatives:

Ensuring Markets for New Drugs and Vaccines

The International Task Force on Global Public Goods has received the paper it commissioned from Ron Ridker, which looks at the options for advance market commitments to increase incentives for the development of new drugs and vaccines.

The paper concludes that an advance market commitment could be effective both for late stage and early stage products, and makes recommendations about how it might be taken forward by the international community.

You can see the paper here.

MCC Board Approves Honduras Proposal

A month after the MCC signed its first compact with Madagascar, the Board of Directors has approved a compact with Honduras. The five-year $215 million compact approved on May 20 aims to boost rural development and revamp a weak transportation infrastructure.

Pages